-
Apr. 2018
LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health
-
Mar. 2018
Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation
-
Sep. 2017
LEUKOCARE continues to expand and invests in research and development
-
Feb. 2017
Rentschler and Leukocare announce strategic alliance and equity investment
-
Sep. 2016
LEUKOCARE grants license to US vaccine company PaxVax
-
Jul. 2016
Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.
-
Mar. 2016
LEUKOCARE launches comprehensive website update
-
Jul. 2015
LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts
-
Apr. 2015
LEUKOCARE participates in European consortium to validate blood-based biomarkers for cancer
-
Apr. 2014
New book release covering Biofunctional Surface Engineering of medical devices